Molecular Characteristics of Spontaneous Remission in Major Depressive Disorder: Changes in Serum Acetylcarnitine and...

Spontaneous remission may influence the outcome of clinical trials and evaluation of antidepressant efficacy, as it is associated with placebo effects and false remission rates. However, the characteristics of spontaneous remission and its biological mechanisms remain poorly understood. This study aimed to explore the metabolic signatures and underlying biological mechanisms of spontaneous remission using metabolomics.

This study conducted untargeted and targeted metabolomic analyses in a discovery cohort (n = 16) comprising patients with major depressive disorder (MDD) and those who were spontaneously remitted without medication. Findings were validated in an independent cohort (n = 185), comprising drug-treated patients and healthy controls.

Acetylcarnitine levels were significantly increased in spontaneous remission compared to depression, whereas glycerophosphocholine levels were decreased in spontaneous remission. Both metabolites showed the highest concentration in the control group, followed by the remission group, and the lowest concentration in the depression group, regardless of medication status. These changes suggest alterations in mitochondrial and membrane lipid metabolism.

Altered levels in acetylcarnitine and glycerophosphocholine may reflect key pathogenic mechanisms of MDD. These findings offer new insight into spontaneous remission as a distinct clinical subtype of depression and may highlight the potential of these metabolites as biomarkers for treatment monitoring in MDD.